Azithromycin and the microbiota of cystic fibrosis sputum

BACKGROUND: Azithromycin is commonly prescribed drug for individuals with cystic fibrosis (CF), with demonstrated benefits in reducing lung function decline, exacerbation occurrence and improving nutrition. As azithromycin has antimicrobial activity against components of the uncultured microbiome an...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:BMC Microbiol
Hoofdauteurs: Acosta, Nicole, Thornton, Christina S., Surette, Michael G., Somayaji, Ranjani, Rossi, Laura, Rabin, Harvey R., Parkins, Michael D.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2021
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8008652/
https://ncbi.nlm.nih.gov/pubmed/33784986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12866-021-02159-5
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items